K
Kelsey N Womack
Researcher at Vanderbilt University Medical Center
Publications - 8
Citations - 1229
Kelsey N Womack is an academic researcher from Vanderbilt University Medical Center. The author has contributed to research in topics: Vaccination & Population. The author has an hindex of 5, co-authored 8 publications receiving 203 citations. Previous affiliations of Kelsey N Womack include Vanderbilt University.
Papers
More filters
Journal ArticleDOI
Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity.
Mark W Tenforde,Wesley H. Self,Katherine Adams,Manjusha Gaglani,Adit A. Ginde,Tresa McNeal,Shekhar Ghamande,David J. Douin,H. Keipp Talbot,Jonathan D Casey,Nicholas M. Mohr,Anne Zepeski,Nathan I. Shapiro,Kevin W Gibbs,D. Clark Files,David N. Hager,Arber Shehu,Matthew E. Prekker,Heidi L Erickson,Matthew C. Exline,Michelle N. Gong,Amira Mohamed,Daniel J. Henning,Jay S. Steingrub,Ithan D. Peltan,Samuel M. Brown,Emily T. Martin,Arnold S. Monto,Akram Khan,Catherine L. Hough,Laurence W. Busse,Caitlin C Ten Lohuis,Abhijit Duggal,Jennifer G. Wilson,Alexandra June Gordon,Nida Qadir,Steven Y. Chang,Christopher Mallow,Carolina Rivas,Hilary M. Babcock,Jennie H. Kwon,Natasha B. Halasa,James D. Chappell,Adam S. Lauring,Carlos G. Grijalva,Todd W. Rice,Ian Jones,William B Stubblefield,Adrienne Baughman,Kelsey N Womack,Jillian P. Rhoads,Christopher J. Lindsell,Kimberly W. Hart,Yuwei Zhu,Samantha M. Olson,Miwako Kobayashi,Jennifer R. Verani,Manish M. Patel,Influenza +58 more
TL;DR: In this article, the authors evaluated the association between vaccination with mRNA COVID-19 vaccines and hospitalization, and the association with progression to critical disease, using multivariable logistic regression.
Journal ArticleDOI
Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions - United States, March-August 2021.
Wesley H. Self,Mark W Tenforde,Jillian P. Rhoads,Manjusha Gaglani,Manjusha Gaglani,Adit A. Ginde,David J. Douin,Samantha M. Olson,H. Keipp Talbot,Jonathan D Casey,Nicholas M. Mohr,Anne Zepeski,Tresa McNeal,Tresa McNeal,Shekhar Ghamande,Shekhar Ghamande,Kevin W Gibbs,D. Clark Files,David N. Hager,Arber Shehu,Matthew E. Prekker,Heidi L Erickson,Michelle N. Gong,Amira Mohamed,Daniel J. Henning,Jay S. Steingrub,Ithan D. Peltan,Samuel M. Brown,Emily T. Martin,Arnold S. Monto,Akram Khan,Catherine L. Hough,Laurence W. Busse,Caitlin C Ten Lohuis,Abhijit Duggal,Jennifer G. Wilson,Alexandra June Gordon,Nida Qadir,Steven Y. Chang,Christopher Mallow,Carolina Rivas,Hilary M. Babcock,Jennie H. Kwon,Matthew C. Exline,Natasha B. Halasa,James D. Chappell,Adam S. Lauring,Carlos G. Grijalva,Todd W. Rice,Ian Jones,William B. Stubblefield,Adrienne Baughman,Kelsey N Womack,Christopher J. Lindsell,Kimberly W. Hart,Yuwei Zhu,Lisa Mills,Sandra N. Lester,Megan M. Stump,Eric A. Naioti,Miwako Kobayashi,Jennifer R. Verani,Natalie J. Thornburg,Manish M. Patel +63 more
TL;DR: In this paper, a case-control analysis was conducted among 3,689 adults aged ≥18 years who were hospitalized at 21 U.S. hospitals across 18 states during March 11-August 15, 2021.
Journal ArticleDOI
Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years - United States, January-March 2021.
Mark W Tenforde,Samantha M. Olson,Wesley H. Self,H. Keipp Talbot,Christopher J. Lindsell,Jay S. Steingrub,Nathan I. Shapiro,Adit A. Ginde,David J. Douin,Matthew E. Prekker,Samuel M. Brown,Ithan D. Peltan,Michelle N. Gong,Amira Mohamed,Akram Khan,Matthew C. Exline,D. Clark Files,Kevin W Gibbs,William B. Stubblefield,Jonathan D Casey,Todd W. Rice,Carlos G. Grijalva,David N. Hager,Arber Shehu,Nida Qadir,Steven Y. Chang,Jennifer G. Wilson,Manjusha Gaglani,Kempapura Murthy,Nicole Calhoun,Arnold S. Monto,Emily T. Martin,Anurag N. Malani,Richard K. Zimmerman,Fernanda P. Silveira,Donald B Middleton,Yuwei Zhu,Dayna Wyatt,Meagan Stephenson,Adrienne Baughman,Kelsey N Womack,Kimberly W. Hart,Miwako Kobayashi,Jennifer R. Verani,Manish M. Patel +44 more
TL;DR: In this paper, the effectiveness of partial or full vaccination with Pfizer-BioNTech or Moderna vaccines against COVID-19-associated hospitalization was assessed among adults aged ≥ 65 years.
Journal ArticleDOI
Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults - United States, March-July 2021.
Mark W Tenforde,Wesley H. Self,Eric A. Naioti,Adit A. Ginde,David J. Douin,Samantha M. Olson,H. Keipp Talbot,Jonathan D Casey,Nicholas M. Mohr,Anne Zepeski,Manjusha Gaglani,Manjusha Gaglani,Tresa McNeal,Shekhar Ghamande,Nathan I. Shapiro,Kevin W Gibbs,D. Clark Files,David N. Hager,Arber Shehu,Matthew E. Prekker,Heidi L Erickson,Michelle N. Gong,Amira Mohamed,Daniel J. Henning,Jay S. Steingrub,Ithan D. Peltan,Samuel M. Brown,Emily T. Martin,Arnold S. Monto,Akram Khan,Catherine L. Hough,Laurence W. Busse,Caitlin C Ten Lohuis,Abhijit Duggal,Jennifer G. Wilson,Alexandra June Gordon,Nida Qadir,Steven Y. Chang,Christopher Mallow,Carolina Rivas,Hilary M. Babcock,Jennie H. Kwon,Matthew C. Exline,Natasha B. Halasa,James D. Chappell,Adam S. Lauring,Carlos G. Grijalva,Todd W. Rice,Ian Jones,William B. Stubblefield,Adrienne Baughman,Kelsey N Womack,Christopher J. Lindsell,Kimberly W. Hart,Yuwei Zhu,Meagan Stephenson,Stephanie J. Schrag,Miwako Kobayashi,Jennifer R. Verani,Manish M. Patel +59 more
TL;DR: In this article, Pfizer-BioNTech or Moderna mRNA COVID-19 vaccines were evaluated in 21 hospitals in 18 states and the duration of mRNA vaccine effectiveness against COVID19-associated hospitalizations was assessed among adults aged ≥18 years.
Journal ArticleDOI
Effectiveness of SARS-CoV-2 mRNA Vaccines for Preventing Covid-19 Hospitalizations in the United States.
Mark W Tenforde,Manish M. Patel,Adit A. Ginde,David J. Douin,H. Keipp Talbot,Jonathan D Casey,Nicholas M. Mohr,Anne Zepeski,Manjusha Gaglani,Tresa McNeal,Shekhar Ghamande,Nathan I. Shapiro,Kevin W Gibbs,D. Clark Files,David N. Hager,Arber Shehu,Matthew E. Prekker,Heidi L Erickson,Matthew C. Exline,Michelle N. Gong,Amira Mohamed,Daniel J. Henning,Ithan D. Peltan,Samuel M. Brown,Emily T. Martin,Arnold S. Monto,Akram Khan,C Terri Hough,Laurence W. Busse,Caitlin C Ten Lohuis,Abhijit Duggal,Jennifer G. Wilson,Alexandra June Gordon,Nida Qadir,Steven Y. Chang,Christopher Mallow,Hayley B. Gershengorn,Hilary M. Babcock,Jennie H. Kwon,Natasha B. Halasa,James D. Chappell,Adam S. Lauring,Carlos G. Grijalva,Todd W. Rice,Ian Jones,William B Stubblefield,Adrienne Baughman,Kelsey N Womack,Christopher J. Lindsell,Kimberly W. Hart +49 more
TL;DR: In a multicenter case-control analysis of US adults hospitalized March 11-May 5, 2021, the authors evaluated vaccine effectiveness to prevent Covid-19 hospitalizations by comparing odds of prior vaccination with an mRNA vaccine (Pfizer-BioNTech or Moderna) between cases hospitalized with Covid19 and hospital-based controls who tested negative for SARS-CoV-2.